Therapeutics

The Institut Pasteur contributes to the discovery of new treatments for diseases with priority given to the fight against the persistence of infectious risk and the occurrence of emerging diseases. We are also involved in immunology, cancer and neuroscience. To speed up the transfer of basic research to future medical breakthroughs we seek to establish collaboration agreements and co-development partnerships with exclusive industrial property benefits for our partners.

 

List of invention disclosures available by therapeutic area

 

 

Invention

Disclosure

Main Inventor

Title

Neuroregeneration

08-88/11-20

M. Lafon

Viral polypeptide inducing neuron survival and regeneration, polynucleotides encoding them and therapeutic uses thereof

Inflammation

10-15/11-25

C. Demangel

Structural variants of mycolactone for use in modulating inflammation

10-36/10-37/12-46

P. Bruhns

A cocktail of two blocking antibodies, targeting human anti-hFgcR mAbs to treat rheumatoid arthritis, inflammation and/or allergic shock

Pain Management

10-15/11-25

C. Demangel

Structural variants of mycolactone for use in modulating pain

Infections

10-35

S. Pochet

Inhibitors of NAD kinase acting on S. aureus and related Gram + bacteria

Oncology

11-12

R.S. Weil

Optineurin-derived polypeptides, their nucleic acids and uses thereof

in particular uses in treating cancer(s) or in treating a disease involving mitosis deregulation(s) or alteration(s)

11-37

N. Wolff

Design of anti-proliferative peptides

 

Updated on 14/02/2014

donation_form_widget.jpg

Contact & address


Laure Tribout 

Research Applications and Industrial Partnerships Department

Institut Pasteur

28 rue du Docteur Roux

75724 Paris Cedex 15 – France

Document for download

MTA